Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Corporate Highlights from Q3 2024 and To Date

Received FDA Approval to initiate pivotal clinical study for Acclaim fully implantable cochlear implant to support eventual PMA submission

AMA approved new CPT codes for totally implantable middle ear hearing implants, which provides significant opportunity for Esteem® FIAMEI

Considerable support voiced for the bi-partisan House and Senate bills to change classification for fully implanted middle ear hearing devices to become coverable benefits for Medicare beneficiaries

U.S. Patent issued for Recharge System with Implantable Battery

European Patent Agency issued Patent for Modular Cochlear Implant System

Company included in Russell Microcap Index